Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CLIA
Veridien Climate Action ETF
$18.61
-0.2%
$18.61
$16.48
$21.28
$23.45M1.349,925 shs75,500 shs
KraneShares MSCI One Belt One Road Index ETF stock logo
OBOR
KraneShares MSCI One Belt One Road Index ETF
$26.90
+0.9%
$27.74
$23.00
$30.07
$2.69M0.434,242 shs575 shs
ODDS
Pacer BlueStar Digital Entertainment ETF
$25.01
-1.3%
$24.32
$22.61
$35.52
$4.00M1.11,182 shs175 shs
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
$24.53
$24.56
$21.70
$27.28
$4.17M0.42,067 shs2,057 shs
The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CLIA
Veridien Climate Action ETF
0.00%0.00%0.00%0.00%0.00%
KraneShares MSCI One Belt One Road Index ETF stock logo
OBOR
KraneShares MSCI One Belt One Road Index ETF
+2.38%-2.42%-6.39%-4.24%+13.89%
ODDS
Pacer BlueStar Digital Entertainment ETF
0.00%+1.58%+4.64%+2.88%-14.53%
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
+2.25%+0.16%-1.60%+0.95%+3.63%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CLIA
Veridien Climate Action ETF
$18.61
-0.2%
$18.61
$16.48
$21.28
$23.45M1.349,925 shs75,500 shs
KraneShares MSCI One Belt One Road Index ETF stock logo
OBOR
KraneShares MSCI One Belt One Road Index ETF
$26.90
+0.9%
$27.74
$23.00
$30.07
$2.69M0.434,242 shs575 shs
ODDS
Pacer BlueStar Digital Entertainment ETF
$25.01
-1.3%
$24.32
$22.61
$35.52
$4.00M1.11,182 shs175 shs
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
$24.53
$24.56
$21.70
$27.28
$4.17M0.42,067 shs2,057 shs
The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CLIA
Veridien Climate Action ETF
0.00%0.00%0.00%0.00%0.00%
KraneShares MSCI One Belt One Road Index ETF stock logo
OBOR
KraneShares MSCI One Belt One Road Index ETF
+2.38%-2.42%-6.39%-4.24%+13.89%
ODDS
Pacer BlueStar Digital Entertainment ETF
0.00%+1.58%+4.64%+2.88%-14.53%
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
+2.25%+0.16%-1.60%+0.95%+3.63%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CLIA
Veridien Climate Action ETF
2.48
Hold$18.61N/A
KraneShares MSCI One Belt One Road Index ETF stock logo
OBOR
KraneShares MSCI One Belt One Road Index ETF
1.00
Strong Sell$26.90N/A
ODDS
Pacer BlueStar Digital Entertainment ETF
2.67
Moderate Buy$25.01N/A
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
2.60
Moderate Buy$24.53N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CLIA
Veridien Climate Action ETF
N/AN/AN/AN/AN/AN/A
KraneShares MSCI One Belt One Road Index ETF stock logo
OBOR
KraneShares MSCI One Belt One Road Index ETF
N/AN/AN/AN/AN/AN/A
ODDS
Pacer BlueStar Digital Entertainment ETF
N/AN/AN/AN/AN/AN/A
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CLIA
Veridien Climate Action ETF
N/AN/A16.68N/AN/AN/AN/AN/AN/A
KraneShares MSCI One Belt One Road Index ETF stock logo
OBOR
KraneShares MSCI One Belt One Road Index ETF
N/AN/A11.41N/AN/AN/AN/AN/AN/A
ODDS
Pacer BlueStar Digital Entertainment ETF
N/AN/A24.94N/AN/AN/AN/AN/AN/A
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
N/AN/A24.31N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CLIA
Veridien Climate Action ETF
N/AN/AN/AN/AN/A
KraneShares MSCI One Belt One Road Index ETF stock logo
OBOR
KraneShares MSCI One Belt One Road Index ETF
$0.813.01%N/AN/AN/A
ODDS
Pacer BlueStar Digital Entertainment ETF
$0.170.68%N/AN/AN/A
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
$0.220.90%N/AN/AN/A

Latest THNR, CLIA, OBOR, and ODDS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/3/2026
ODDS
Pacer BlueStar Digital Entertainment ETF
$0.11686/4/20266/4/20266/8/2026
(Data available from 1/1/2013 forward)
CompanyEmployeesShares OutstandingFree FloatOptionable
CLIA
Veridien Climate Action ETF
N/A1.26 millionN/ANot Optionable
KraneShares MSCI One Belt One Road Index ETF stock logo
OBOR
KraneShares MSCI One Belt One Road Index ETF
N/A100,000N/ANot Optionable
ODDS
Pacer BlueStar Digital Entertainment ETF
N/A160,000N/AOptionable
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
N/A170,000N/AN/A

Recent News About These Companies

Healthcare ETFs: From Broad Exposure to Big Breakthroughs
New Year, New Strategy: Navigating Weight Loss ETFs
Tap the Weight-Loss Drug Market With These ETFs
Disruptive Theme of the Week: Playing Defense

Media Sentiment Over Time

Veridien Climate Action ETF NYSEARCA:CLIA

$18.61 -0.04 (-0.21%)
As of 08/16/2024

The Veridien Climate Action ETF (CLIA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed, non-transparent ETF that seeks to invest in companies, via US-listed stocks or ADRs from around the world, that are considered to be making a substantial contribution to mitigating climate change. The fund utilizes the Precidian non-transparent model CLIA was launched on May 8, 2023 and is managed by Veridien.

KraneShares MSCI One Belt One Road Index ETF stock logo

KraneShares MSCI One Belt One Road Index ETF NYSEARCA:OBOR

$26.90 +0.25 (+0.94%)
As of 10:03 AM Eastern

The KraneShares MSCI One Belt One Road Index ETF (OBOR) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected, tier-weighted index of companies likely to benefit from China's One Belt, One Road initiative. OBOR was launched on Sep 7, 2017 and is managed by KraneShares.

Pacer BlueStar Digital Entertainment ETF NASDAQ:ODDS

$25.01 -0.34 (-1.34%)
As of 06/10/2026 11:44 AM Eastern

The Pacer BlueStar Digital Entertainment ETF (ODDS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a tier-weighted index of globally-listed companies that focuses on the digital entertainment industry, including online gambling, video gaming, content streaming, and eSports. ODDS was launched on Apr 8, 2022 and is managed by Pacer.

Amplify Weight Loss Drug & Treatment ETF stock logo

Amplify Weight Loss Drug & Treatment ETF NYSEARCA:THNR

$24.53 0.00 (0.00%)
As of 06/11/2026 04:10 PM Eastern

The Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that is based on the VettaFi Weight Loss Drug index. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.